+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biopharmaceutical Excipients Market - Global Forecast to 2030- Product Image
Biopharmaceutical Excipients Market - Global Forecast to 2030- Product Image
Sale

Biopharmaceutical Excipients Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337416
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biopharmaceutical Excipients Market grew from USD 3.61 billion in 2024 to USD 3.96 billion in 2025. It is expected to continue growing at a CAGR of 9.69%, reaching USD 6.30 billion by 2030.

Biopharmaceutical excipients serve as the unsung heroes of drug development and manufacturing, offering functionality beyond mere carriers for active pharmaceutical ingredients. From enhancing solubility and stability to controlling release kinetics and improving patient compliance, these inert materials are essential to the performance, safety, and quality of biopharmaceutical products. As complex biologics and novel delivery systems gain prominence, the demand for specialized excipient solutions intensifies, driven by innovation in formulation science. This executive summary explores the current state of the excipient landscape, spotlighting key drivers, emerging challenges, and critical considerations for formulation scientists and decision-makers. By setting the stage with a concise overview of market dynamics and regulatory trends, we establish the foundation for deeper insights into transformative shifts, tariff impacts, segmentation nuances, regional variations, and competitive intelligence. This introduction underscores the strategic importance of excipients as enablers of therapeutic breakthroughs and frames the subsequent analysis through a lens of actionable intelligence and industry foresight.

Transformative Shifts in the Biopharmaceutical Excipients Landscape

The landscape of biopharmaceutical excipients is undergoing profound transformation as technological advancements and shifting regulatory priorities converge. Recent breakthroughs in controlled-release coatings and novel polymeric binders are redefining formulation possibilities, enabling more precise modulation of drug release profiles and enhanced patient adherence. Concurrently, the rise of complex modalities such as mRNA vaccines and gene therapies has prompted a surge in demand for excipients with unique stabilizing and delivery capabilities, such as advanced lipids and specialized surfactants. Moreover, sustainability considerations are driving research into natural and biodegradable excipients, prompting companies to explore cellulose derivatives, polysaccharides, and plant-based polymers as viable alternatives to traditional synthetic materials. Digitalization and automation in manufacturing further accelerate changes, with continuous processing platforms and real-time analytics shaping excipient selection and validation. Collectively, these transformative shifts herald a new era in which excipients play an increasingly strategic role in enabling next-generation biopharmaceuticals.

Cumulative Impact of United States Tariffs 2025

In 2025, the cumulative impact of revised United States tariffs has introduced both challenges and opportunities for excipient suppliers and formulators. Increased duties on select polymeric and specialty surfactant imports have elevated raw material costs, compelling manufacturers to reassess supply chain strategies and explore alternative sourcing. At the same time, the tariff adjustments have incentivized domestic production of key excipients, leading to capacity expansions and investments in local manufacturing technologies. As a result, supply chain resilience has improved through greater geographic diversification, while lead times have shortened for domestically produced excipients with high demand. Importantly, formulators are responding by optimizing formulations to reduce dependence on tariff-impacted materials, leveraging multifunctional excipients that combine binding, lubrication, and disintegration properties. These strategic adaptations have fostered greater cost efficiency and supply predictability, illustrating how regulatory shifts can catalyze innovation and strengthen the domestic excipient ecosystem.

Key Segmentation Insights

A nuanced understanding of market segmentation reveals critical insights into product performance requirements and sourcing strategies. Across binders, coatings, diluents, disintegrants, lubricants and glidants, polyols, preservatives, solubilizers and surfactants/emulsifiers, and suspending and viscosity agents, each category reflects distinct functional imperatives: binders such as cellulosic binders, hydroxypropyl methylcellulose, povidone and starch derivatives ensure tablet integrity; coatings including controlled-release, enteric, film, seal and sugar variants enable targeted delivery; diluents like calcium phosphates, lactose and microcrystalline cellulose provide bulk and compressibility; polyols such as mannitol and sorbitol impart sweetness and stability; and solubilizers and surfactants, whether esters, polysorbates or triglycerides, enhance bioavailability of poorly soluble actives. When viewed through the source lens of natural versus synthetic excipients, formulation strategies diverge between sustainability-focused biopolymers and high-purity laboratory-synthesized molecules. Formulation type segmentation spanning injectable, oral and topical dosage forms underscores tailored excipient requirements: injectable solutions benefit from ultrafine surfactants and sterile-grade preservatives; oral capsules, powders and tablets depend on carefully balanced binders and disintegrants; and topical creams, gels, ointments and lotions require specific viscosity and moisturizing agents. Finally, end-user segmentation among biopharmaceutical and pharmaceutical companies, contract manufacturers and research institutes highlights differing priorities: large drug developers emphasize regulatory compliance and scalability, CMOs focus on turnkey formulation platforms, and academic or government labs prioritize flexibility and exploratory testing.

Key Regional Insights

Regional dynamics play a pivotal role in shaping excipient availability, regulatory frameworks and cost structures across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, a robust domestic manufacturing base combined with favorable trade agreements supports competitive pricing for major excipient classes, while stringent FDA regulations drive demand for high-purity, GMP-certified materials. Transitioning to Europe, Middle East & Africa, excipient suppliers navigate a complex mosaic of EMA and local regulatory approvals, with sustainability initiatives and REACH compliance elevating the profile of bio-based and low-environmental-impact materials. The Asia-Pacific region, characterized by rapid expansion in biopharmaceutical R&D hubs and contract manufacturing, exhibits growing investment in local excipient production, particularly in China, India and South Korea, where cost competitiveness and shorter lead times are compelling factors. Furthermore, emerging markets within EMEA and APAC are leveraging government incentives to develop specialized excipient clusters, thereby enhancing regional self-sufficiency and reducing reliance on long-haul supply chains.

Key Company Insights

Competitive dynamics among leading excipient suppliers reflect intense focus on product innovation, geographic expansion and strategic partnerships. ABITEC Corporation and Actylis are advancing specialty lipid excipients for complex parenteral formulations, while Asahi Kasei Corporation leverages proprietary polymers in controlled-release platforms. Ashland Inc. and Avantor, Inc. continue to broaden their portfolios through acquisitions and co-development agreements, ensuring comprehensive coverage across binder, coating and surfactant classes. Major chemical companies such as BASF SE, Clariant International Ltd., Croda International PLC and Evonik Industries AG differentiate through high-precision processing and regulatory support services. Niche specialists like DFE Pharma GmbH & Co KG, JRS PHARMA GmbH + Co. KG and Sigachi Industries Limited focus on targeted formulations and regional markets. Global conglomerates including The Dow Chemical Company, The Lubrizol Corporation and Wacker Chemie AG maintain leadership in polymeric excipients, while life science distributors such as IMCD N.V. and Spectrum Laboratory Products, Inc. optimize supply chain logistics. In parallel, biopolymer pioneers Roquette Frères S.A., Kerry Group PLC and Meggle Group GmbH invest in sustainable sourcing, and industry stalwarts Merck KGaA, Mitsubishi Chemical Group Corporation and NOF Corporation emphasize quality consistency for injectable and oral dosage forms.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize three strategic imperatives to capitalize on evolving excipient demands. First, forge collaborative partnerships with suppliers of multifunctional and sustainable excipients to accelerate formulation innovation while mitigating supply risks. Second, invest in advanced manufacturing technologies, including continuous processing and real-time release testing, to enhance process efficiency, reduce batch variability and comply with tightening regulatory standards. Third, develop agile sourcing strategies that balance domestic production with geographically diversified imports, thereby insulating operations from tariff fluctuations and logistical disruptions. Additionally, establish integrated data platforms to monitor quality metrics, regulatory updates and market trends, enabling proactive decision-making. By aligning R&D, procurement and regulatory affairs around these actionable priorities, companies can optimize cost structures, enhance product differentiation and secure a competitive edge in the biopharmaceutical excipient market.

Conclusion: Positioning for Excipient Excellence

In summary, biopharmaceutical excipients are evolving from supportive ingredients into strategic assets that underpin formulation innovation, regulatory compliance and supply chain resilience. Technological advancements, regulatory dynamics and sustainability imperatives are driving unprecedented change, while tariff adjustments and regional developments are reshaping sourcing and manufacturing paradigms. As the market becomes increasingly complex, a comprehensive understanding of segmentation nuances, competitive landscapes and regional variations is essential. Leveraging these insights, stakeholders can refine their formulation toolkits, optimize procurement strategies and foster partnerships that accelerate therapeutic development. Ultimately, excipient excellence will continue to play a decisive role in bringing safe, effective and patient-centric biopharmaceutical products to market.

Market Segmentation & Coverage

This research report categorizes the Biopharmaceutical Excipients Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Binders
    • Cellulosic Binders
    • Hydroxypropyl Methylcellulose (HPMC)
    • Povidone (Polyvinylpyrrolidone or PVP)
    • Starch & Modified Starches
  • Coatings
    • Controlled Release Coatings
    • Enteric Coatings
    • Film Coatings
    • Seal Coatings
    • Sugar Coatings
  • Diluents
    • Calcium Phosphates
    • Lactose
    • Microcrystalline Cellulose
  • Disintegrants
  • Lubricants & Glidants
  • Polyols
    • Mannitol
    • Sorbitol
  • Preservatives
  • Solubilizers & Surfactants/Emulsifiers
    • Esters
    • Polysorbates
    • Triglycerides
  • Suspending & Viscosity Agents
  • Natural Excipients
  • Synthetic Excipients
  • Injectable Formulations
    • Intramuscular
    • Intravenous
    • Subcutaneous
  • Oral Formulations
    • Capsules
    • Powders
    • Tablets
  • Topical Formulations
    • Creams
    • Gels & Ointments
    • Lotions
  • Biopharmaceutical & Pharmaceutical Companies
  • Contract Manufacturers
  • Research Institutes

This research report categorizes the Biopharmaceutical Excipients Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • Massachusetts
      • New York
      • North Carolina
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Biopharmaceutical Excipients Market to delves into recent significant developments and analyze trends in each of the following companies:

  • ABITEC Corporation
  • Actylis
  • Asahi Kasei Corporation
  • Ashland Inc.
  • Avantor, Inc.
  • BASF SE
  • Clariant International Ltd.
  • Colorcon Ltd.
  • Croda International PLC
  • DFE Pharma GmbH & Co KG
  • Eastman Chemical Company
  • Evonik Industries AG
  • Fuji Chemical Industries Co., Ltd.
  • IMCD N.V.
  • Innophos Holdings, Inc.
  • International Flavors & Fragrances Inc.
  • JRS PHARMA GmbH + Co. KG
  • Kerry Group PLC
  • Meggle Group GmbH
  • Merck KGaA
  • Mitsubishi Chemical Group Corporation
  • NOF Corporation
  • Novo Nordisk A/S
  • Pfanstiehl, Inc.
  • Roquette Frères S.A.
  • Shin-Etsu Chemical Co., Ltd.
  • Sigachi Industries Limited
  • Spectrum Laboratory Products, Inc.
  • SPI Pharma, Inc. By Associated British Foods
  • The Archer-Daniels-Midland Company
  • The Dow Chemical Company
  • The Lubrizol Corporation
  • Wacker Chemie AG

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biopharmaceutical Excipients Market, by Product
8.1. Introduction
8.2. Binders
8.2.1. Cellulosic Binders
8.2.2. Hydroxypropyl Methylcellulose (HPMC)
8.2.3. Povidone (Polyvinylpyrrolidone or PVP)
8.2.4. Starch & Modified Starches
8.3. Coatings
8.3.1. Controlled Release Coatings
8.3.2. Enteric Coatings
8.3.3. Film Coatings
8.3.4. Seal Coatings
8.3.5. Sugar Coatings
8.4. Diluents
8.4.1. Calcium Phosphates
8.4.2. Lactose
8.4.3. Microcrystalline Cellulose
8.5. Disintegrants
8.6. Lubricants & Glidants
8.7. Polyols
8.7.1. Mannitol
8.7.2. Sorbitol
8.8. Preservatives
8.9. Solubilizers & Surfactants/Emulsifiers
8.9.1. Esters
8.9.2. Polysorbates
8.9.3. Triglycerides
8.10. Suspending & Viscosity Agents
9. Biopharmaceutical Excipients Market, by Source
9.1. Introduction
9.2. Natural Excipients
9.3. Synthetic Excipients
10. Biopharmaceutical Excipients Market, by Formulation Type
10.1. Introduction
10.2. Injectable Formulations
10.2.1. Intramuscular
10.2.2. Intravenous
10.2.3. Subcutaneous
10.3. Oral Formulations
10.3.1. Capsules
10.3.2. Powders
10.3.3. Tablets
10.4. Topical Formulations
10.4.1. Creams
10.4.2. Gels & Ointments
10.4.3. Lotions
11. Biopharmaceutical Excipients Market, by End User
11.1. Introduction
11.2. Biopharmaceutical & Pharmaceutical Companies
11.3. Contract Manufacturers
11.4. Research Institutes
12. Americas Biopharmaceutical Excipients Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Biopharmaceutical Excipients Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Biopharmaceutical Excipients Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. ABITEC Corporation
15.3.2. Actylis
15.3.3. Asahi Kasei Corporation
15.3.4. Ashland Inc.
15.3.5. Avantor, Inc.
15.3.6. BASF SE
15.3.7. Clariant International Ltd.
15.3.8. Colorcon Ltd.
15.3.9. Croda International PLC
15.3.10. DFE Pharma GmbH & Co KG
15.3.11. Eastman Chemical Company
15.3.12. Evonik Industries AG
15.3.13. Fuji Chemical Industries Co., Ltd.
15.3.14. IMCD N.V.
15.3.15. Innophos Holdings, Inc.
15.3.16. International Flavors & Fragrances Inc.
15.3.17. JRS PHARMA GmbH + Co. KG
15.3.18. Kerry Group PLC
15.3.19. Meggle Group GmbH
15.3.20. Merck KGaA
15.3.21. Mitsubishi Chemical Group Corporation
15.3.22. NOF Corporation
15.3.23. Novo Nordisk A/S
15.3.24. Pfanstiehl, Inc.
15.3.25. Roquette Frères S.A.
15.3.26. Shin-Etsu Chemical Co., Ltd.
15.3.27. Sigachi Industries Limited
15.3.28. Spectrum Laboratory Products, Inc.
15.3.29. SPI Pharma, Inc. By Associated British Foods
15.3.30. The Archer-Daniels-Midland Company
15.3.31. The Dow Chemical Company
15.3.32. The Lubrizol Corporation
15.3.33. Wacker Chemie AG
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BIOPHARMACEUTICAL EXCIPIENTS MARKET MULTI-CURRENCY
FIGURE 2. BIOPHARMACEUTICAL EXCIPIENTS MARKET MULTI-LANGUAGE
FIGURE 3. BIOPHARMACEUTICAL EXCIPIENTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BIOPHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BIOPHARMACEUTICAL EXCIPIENTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOPHARMACEUTICAL EXCIPIENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSIC BINDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE (HPMC), BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POVIDONE (POLYVINYLPYRROLIDONE OR PVP), BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH & MODIFIED STARCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTROLLED RELEASE COATINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ENTERIC COATINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FILM COATINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SEAL COATINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGAR COATINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CALCIUM PHOSPHATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LACTOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYSORBATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY NATURAL EXCIPIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SYNTHETIC EXCIPIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GELS & OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LOTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTRACT MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2030 (USD MILLION)
TABLE 100. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2030 (USD MILLION)
TABLE 101. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2030 (USD MILLION)
TABLE 102. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
TABLE 103. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
TABLE 104. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 105. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 106. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 107. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 108. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 109. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2030 (USD MILLION)
TABLE 112. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2030 (USD MILLION)
TABLE 113. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2030 (USD MILLION)
TABLE 114. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
TABLE 115. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
TABLE 116. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 117. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 118. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 119. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 120. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 121. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 146. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 148. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2030 (USD MILLION)
TABLE 150. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2030 (USD MILLION)
TABLE 151. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2030 (USD MILLION)
TABLE 152. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 157. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 158. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 159. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2030 (USD MILLION)
TABLE 162. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2030 (USD MILLION)
TABLE 163. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2030 (USD MILLION)
TABLE 164. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
TABLE 165. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
TABLE 166. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 167. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 168. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 169. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 170. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 171. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2030 (USD MILLION)
TABLE 174. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2030 (USD MILLION)
TABLE 175. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2030 (USD MILLION)
TABLE 176. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
TABLE 177. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
TABLE 178. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 179. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 180. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 181. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 182. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 183. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2030 (USD MILLION)
TABLE 186. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2030 (USD MILLION)
TABLE 187. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2030 (USD MILLION)
TABLE 188. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
TABLE 189. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
TABLE 190. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 191. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 192. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 193. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 194. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 195. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 197. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2030 (USD MILLION)
TABLE 198. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2030 (USD MILLION)
TABLE 199. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2030 (USD MILLION)
TABLE 200. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
TABLE 201. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
TABLE 202. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 203. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 204. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 205. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 206. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 207. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 209. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2030 (USD MILLION)
TABLE 210. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2030 (USD MILLION)
TABLE 211. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2030 (USD MILLION)
TABLE 212. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
TABLE 213. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2030 (USD MILLION)
TABLE 222. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2030 (USD MILLION)
TABLE 223. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2030 (USD MILLION)
TABLE 224. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
TABLE 225. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
TABLE 226. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 227. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 228. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 229. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 230. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 231. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 233. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2030 (USD MILLION)
TABLE 234. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2030 (USD MILLION)
TABLE 235. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2030 (USD MILLION)
TABLE 236. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
TABLE 237. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
TABLE 238. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 239. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 240. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 241. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 242. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 243. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 245. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2030 (USD MILLION)
TABLE 246. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2030 (USD MILLION)
TABLE 247. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2030 (USD MILLION)
TABLE 248. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
TABLE 249. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
TABLE 250. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 251. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 252. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 253. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 254. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 255. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 257. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2030 (USD MILLION)
TABLE 258. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2030 (USD MILLION)
TABLE 259. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2030 (USD MILLION)
TABLE 260. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
TABLE 261. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
TABLE 262. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 263. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 264. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 265. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 266. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 267. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 269. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2030 (USD MILLION)
TABLE 270. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2030 (USD MILLION)
TABLE 271. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2030 (USD MILLION)
TABLE 272. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
TABLE 273. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
TABLE 274. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 275. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 276. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 277. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 278. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 279. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 281. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2030 (USD MILLION)
TABLE 282. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2030 (USD MILLION)
TABLE 283. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2030 (USD MILLION)
TABLE 284. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
TABLE 285. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
TABLE 286. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 287. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 288. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 289. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 290. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 291. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2030 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2030 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 305. DENMARK BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 306. DENMARK BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2030 (USD MILLION)
TABLE 307. DENMARK BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2030 (USD MILLION)
TABLE 308. DENMARK BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2030 (USD MILLION)
TABLE 309. DENMARK BIOP

Companies Mentioned

  • ABITEC Corporation
  • Actylis
  • Asahi Kasei Corporation
  • Ashland Inc.
  • Avantor, Inc.
  • BASF SE
  • Clariant International Ltd.
  • Colorcon Ltd.
  • Croda International PLC
  • DFE Pharma GmbH & Co KG
  • Eastman Chemical Company
  • Evonik Industries AG
  • Fuji Chemical Industries Co., Ltd.
  • IMCD N.V.
  • Innophos Holdings, Inc.
  • International Flavors & Fragrances Inc.
  • JRS PHARMA GmbH + Co. KG
  • Kerry Group PLC
  • Meggle Group GmbH
  • Merck KGaA
  • Mitsubishi Chemical Group Corporation
  • NOF Corporation
  • Novo Nordisk A/S
  • Pfanstiehl, Inc.
  • Roquette Frères S.A.
  • Shin-Etsu Chemical Co., Ltd.
  • Sigachi Industries Limited
  • Spectrum Laboratory Products, Inc.
  • SPI Pharma, Inc. By Associated British Foods
  • The Archer-Daniels-Midland Company
  • The Dow Chemical Company
  • The Lubrizol Corporation
  • Wacker Chemie AG

Methodology

Loading
LOADING...

Related Topics

Related Reports

Biopharmaceutical Excipients Market - Focused Insights 2024-2029 - Product Image

Biopharmaceutical Excipients Market - Focused Insights 2024-2029

  • Report
  • 163 Pages
  • Global
From
Lipid-Based Pharma Excipients Market - Global Outlook & Forecast 2025-2030 - Product Image

Lipid-Based Pharma Excipients Market - Global Outlook & Forecast 2025-2030

  • Report
  • 432 Pages
  • Global
From
Pharmaceutical Excipient Market by Type (Inorganic, Organic), Formulation (Oral Formulations, Parenteral Formulations, Topical Formulations), Function, End-User - Global Forecast 2025-2030 - Product Image

Pharmaceutical Excipient Market by Type (Inorganic, Organic), Formulation (Oral Formulations, Parenteral Formulations, Topical Formulations), Function, End-User - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Organic Pharmaceutical Excipients Market by Function, Form, Product - Global Forecast 2025-2030 - Product Image

Organic Pharmaceutical Excipients Market by Function, Form, Product - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Polymer Excipients Market - Forecasts from 2024 to 2029 - Product Image

Polymer Excipients Market - Forecasts from 2024 to 2029

  • Report
  • 141 Pages
  • Global
From

About the Biopharma Excipients Market

The biopharmaceutical excipient market is a subset of the drug discovery industry, which focuses on the development of new drugs and therapies. Excipients are inactive ingredients used to formulate drugs, and are essential for the production of safe and effective medicines. They are used to improve the stability, solubility, and bioavailability of active pharmaceutical ingredients. Excipients also help to protect the drug from environmental factors, such as light and moisture. The biopharmaceutical excipient market is driven by the increasing demand for biopharmaceuticals, as well as the need for improved drug delivery systems. The market is also driven by the growing demand for cost-effective and safe drug formulations. Some of the major companies in the biopharmaceutical excipient market include BASF, Evonik Industries, Ashland, Croda International, and Lubrizol Corporation. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.